269 related articles for article (PubMed ID: 24728145)
1. Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis.
Wu D; Hu M; Hong L; Hong S; Ding W; Min J; Fang G; Guo W
Arch Gynecol Obstet; 2014 Sep; 290(3):513-23. PubMed ID: 24728145
[TBL] [Abstract][Full Text] [Related]
2. [A meta-analysis of preventing bone mineral loss in patients with endometriosis treated by gonadotrophin-releasing hormone analogues with add-back therapy].
Niu ZR; Yue XJ; Kong QY; Wang YF; Yao YQ
Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):338-43. PubMed ID: 24016475
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone analogues for endometriosis.
Veth VB; van de Kar MM; Duffy JM; van Wely M; Mijatovic V; Maas JW
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014788. PubMed ID: 37341141
[TBL] [Abstract][Full Text] [Related]
4. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density.
Sagsveen M; Farmer JE; Prentice A; Breeze A
Cochrane Database Syst Rev; 2003; 2003(4):CD001297. PubMed ID: 14583930
[TBL] [Abstract][Full Text] [Related]
5. Add-back therapy in the treatment of endometriosis-associated pain.
Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
[TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].
Long QQ; Zhang SF; Han Y; Chen H; Li XL; Hua KQ; Hu WG
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):247-51. PubMed ID: 20646533
[TBL] [Abstract][Full Text] [Related]
7. Low-dose add-back therapy during postoperative GnRH agonist treatment.
Tsai HW; Wang PH; Huang BS; Twu NF; Yen MS; Chen YJ
Taiwan J Obstet Gynecol; 2016 Feb; 55(1):55-9. PubMed ID: 26927249
[TBL] [Abstract][Full Text] [Related]
8. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.
Brown J; Pan A; Hart RJ
Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD008475. PubMed ID: 21154398
[TBL] [Abstract][Full Text] [Related]
9. Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
DiVasta AD; Feldman HA; Sadler Gallagher J; Stokes NA; Laufer MR; Hornstein MD; Gordon CM
Obstet Gynecol; 2015 Sep; 126(3):617-627. PubMed ID: 26181088
[TBL] [Abstract][Full Text] [Related]
10. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
[TBL] [Abstract][Full Text] [Related]
11. Current approaches to optimizing the treatment of endometriosis in adolescents.
Laufer MR
Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
13. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis.
Divasta AD; Laufer MR; Gordon CM
J Pediatr Adolesc Gynecol; 2007 Oct; 20(5):293-7. PubMed ID: 17868896
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety investigation of Kuntai capsule for the add-back therapy of gonadotropin releasing hormone agonist administration to endometriosis patients: a randomized, double-blind, blank- and tibolone-controlled study.
Chen JM; Gao HY; Ding Y; Yuan X; Wang Q; Li Q; Jiang GH
Chin Med J (Engl); 2015 Feb; 128(4):427-32. PubMed ID: 25673440
[TBL] [Abstract][Full Text] [Related]
15. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome.
Mitwally MF; Gotlieb L; Casper RF
Menopause; 2002; 9(4):236-41. PubMed ID: 12082359
[TBL] [Abstract][Full Text] [Related]
16. Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group.
Surrey ES
Fertil Steril; 1999 Mar; 71(3):420-4. PubMed ID: 10065775
[TBL] [Abstract][Full Text] [Related]
17. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
Sesti F; Pietropolli A; Capozzolo T; Broccoli P; Pierangeli S; Bollea MR; Piccione E
Fertil Steril; 2007 Dec; 88(6):1541-7. PubMed ID: 17434511
[TBL] [Abstract][Full Text] [Related]
18. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.
Hornstein MD; Surrey ES; Weisberg GW; Casino LA
Obstet Gynecol; 1998 Jan; 91(1):16-24. PubMed ID: 9464714
[TBL] [Abstract][Full Text] [Related]
19. Impact of six months of GnRH agonist therapy for endometriosis. Is there an age-related effect on bone mineral density?
Agarwal SK
J Reprod Med; 2002 Jul; 47(7):530-4. PubMed ID: 12170527
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
Surrey ES
Curr Opin Obstet Gynecol; 2010 Aug; 22(4):283-8. PubMed ID: 20498596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
